Results
|
10801.
|
|
|
10802.
|
|
|
10803.
|
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma. [electronic resource] by
- Pro, Barbara
- Leber, Brian
- Smith, Mitchell
- Fayad, Luis
- Romaguera, Jorge
- Hagemeister, Fredrick
- Rodriguez, Alma
- McLaughlin, Peter
- Samaniego, Felipe
- Zwiebel, James
- Lopez, Adriana
- Kwak, Larry
- Younes, Anas
Producer: 20081222
In:
British journal of haematology vol. 143
Availability: No items available.
|
|
10804.
|
|
|
10805.
|
|
|
10806.
|
|
|
10807.
|
Rituximab (MabThera) therapy and safety management. Clinical tool guide. [electronic resource] by
- Pham, Thao
- Fautrel, Bruno
- Gottenberg, Jacques-Eric
- Goupille, Philippe
- Hachulla, Eric
- Masson, Charles
- Morel, Jacques
- Mouthon, Luc
- Saraux, Alain
- Schaeverbeke, Thierry
- Wendling, Daniel
- Mariette, Xavier
Producer: 20090127
In:
Joint bone spine vol. 75 Suppl 1
Availability: No items available.
|
|
10808.
|
|
|
10809.
|
|
|
10810.
|
|
|
10811.
|
|
|
10812.
|
|
|
10813.
|
Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group. [electronic resource] by
- Kimby, Eva
- Jurlander, Jesper
- Geisler, Christian
- Hagberg, Hans
- Holte, Harald
- Lehtinen, Tuula
- Ostenstad, Björn
- Hansen, Mads
- Osterborg, Anders
- Lindén, Ola
- Sundström, Christer
Producer: 20080416
In:
Leukemia & lymphoma vol. 49
Availability: No items available.
|
|
10814.
|
|
|
10815.
|
Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18fluorodeoxyglucose positron emission tomography to the International Workshop Criteria. [electronic resource] by
- Dupuis, J
- Itti, E
- Rahmouni, A
- Hemery, F
- Gisselbrecht, C
- Lin, C
- Copie-Bergman, C
- Belhadj, K
- El Gnaoui, T
- Gaillard, I
- Kuhnowski, F
- Meignan, M
- Haioun, C
Producer: 20090519
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
10816.
|
|
|
10817.
|
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. [electronic resource] by
- Keystone, E
- Emery, P
- Peterfy, C G
- Tak, P P
- Cohen, S
- Genovese, M C
- Dougados, M
- Burmester, G R
- Greenwald, M
- Kvien, T K
- Williams, S
- Hagerty, D
- Cravets, M W
- Shaw, T
Producer: 20090225
In:
Annals of the rheumatic diseases vol. 68
Availability: No items available.
|
|
10818.
|
|
|
10819.
|
|
|
10820.
|
|